Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.1830
0.00 (0.00%)
Aug 1, 2025, 4:00 PM EDT
Splunk Market Cap
Renalytix has a market cap or net worth of $32.90 million as of August 1, 2025. Its market cap has increased by 18.11% in one year.
Market Cap
32.90M
Enterprise Value
31.40M
Revenue
2.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 32.90M, a decrease of -61.05%. That is a compound annual growth rate of -13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 32.90M | -26.18% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | 479.42M | 67.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |